National Research Corporation (Delaware) (NRC)
$21.12
$-0.14
(-0.66%)
As on 11-Sep-2026 16:00EDT
Market cap
$468 Mln
Revenue (TTM)
$140 Mln
P/E Ratio
88
P/B Ratio
71.3
Div. Yield
2.8 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$0 Mln
-
ROE
0.4 %
-
ROCE
-- %
-
Industry P/E
23.18
-
EV/EBITDA
23.7
-
Debt to Equity
13.1
-
Book Value
$0.3
-
EPS
$0.3
-
Face value
--
-
Shares outstanding
22,139,315
10 Years Aggregate
CFO
$345.14 Mln
EBITDA
$433.22 Mln
Net Profit
$279.18 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
National Research Corporation (Delaware) (NRC)
| 12.5 | 1.1 | -0.8 | 32.9 | -21.8 | -15.5 | 3.1 |
|
BSE Sensex
| -11.7 | -4.8 | 1.1 | -8.2 | 3.9 | 5.1 | 10.0 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
National Research Corporation (Delaware) (NRC)
| 6.4 | -55.1 | 6.1 | -10.2 | -1.8 | -34.8 | 75.5 |
|
S&P Small-Cap 600
| 4.0 | 7.0 | 13.9 | -17.4 | 25.3 | 9.6 | 20.9 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
National Research Corporation (Delaware) (NRC)
|
21.1 | 467.6 | 140.0 | 5.9 | 10.6 | 57 | 88 | 71.3 |
| 86.9 | 4,029.1 | 1,661.6 | 205.4 | 16.2 | 15.4 | 20.3 | 3.0 | |
| 112.0 | 4,611.5 | 5,481.4 | 180.9 | 10.6 | 58.1 | 25.9 | 14.4 | |
| 35.3 | 5,387.1 | 2,237.3 | 250.0 | 15.9 | 28.1 | 22.3 | 6.2 | |
| 148.1 | 4,088.5 | 3,923.7 | 252.8 | 7.6 | 16.5 | 17.9 | 3.1 | |
| 31.5 | 4,144.7 | 2,827.3 | 291.5 | 18.1 | 19.3 | 14.9 | 2.7 | |
| 141.0 | 4,748.6 | 4,856.0 | 49.0 | 11.9 | 2.6 | 83.6 | 2.5 | |
| 182.2 | 7,028.2 | 1,946.3 | 314.0 | 22.9 | 22.7 | 22.6 | 5.0 | |
| 22.0 | 4,654.9 | 1,809.6 | 305.0 | 9.7 | 30.6 | 15.8 | 4.1 | |
| 191.5 | 6,527.3 | 2,792.0 | 350.8 | 25.6 | 27.2 | 19 | 4.8 |
Shareholding Pattern
View DetailsAbout National Research Corporation (Delaware) (NRC)
NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers market experience solutions, a subscription-based services for improved tracking... of awareness, perception, and consistency of healthcare brands; assessment of differentiators; and segmentation tools to evaluate the needs, wants, and behaviors of communities through assessments. It also provides patient experience solutions, a cross-continuum multi-mode digital platform that collects and measures data to improve patient experience, engagement, and loyalty; employee experience solutions, which combines health care with technology comprising engagement, pulse, lifecycle, culture of safety, and magnet RN satisfaction; and consumer experience solution that offers online reputation solutions, community insights, and cross-journey listening through nGage. In addition, the company offers Huey, an AI engine built for Human Understanding that serves as a healthcare experience management companion; and governance solutions provided through national conferences, publications, advisory services, and an online portal for not-for-profit health system boards of directors, executives, and physician leadership. Further, it provides patient experience, service recovery, care transitions, employee engagement, reputation management, rounding, and brand loyalty. The company was formerly known as National Research Corporation and changed its name to NRC Health April 2026. The company was founded in 1981 and is headquartered in Lincoln, Nebraska. Read more
-
Founder, CEO, President & Director
Mr. Michael D. Hays
-
Founder, CEO, President & Director
Mr. Michael D. Hays
-
Headquarters
Lincoln, NE
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for National Research Corporation (Delaware) (NRC)
What is the current share price of National Research Corporation (Delaware) (NRC) Today?
The share price of National Research Corporation (Delaware) (NRC) is $21.12 (NASDAQ) as of 11-Sep-2026 16:00 EDT. National Research Corporation (Delaware) (NRC) has given a return of -21.81% in the last 3 years.
What is the current PB & PE ratio of National Research Corporation (Delaware) (NRC)?
The P/E ratio of National Research Corporation (Delaware) (NRC) is 88.00 times as on 11-Sep-2026, a 280 premium to its peers’ median range of 23.18 times.
The P/B ratio of National Research Corporation (Delaware) (NRC) is 71.33 times as on 11-Sep-2026, a 2457 premium to its peers’ median range of 2.79 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2025 |
35.29 |
29.26 |
2024 |
16.63 |
13.18 |
2023 |
31.36 |
19.84 |
2022 |
29.06 |
12.83 |
2021 |
28.37 |
12.45 |
What is the 52 Week High and Low of National Research Corporation (Delaware) (NRC)?
The 52-week high and low of National Research Corporation (Delaware) (NRC) are Rs 23.68 and Rs 11.01 as of 13-Sep-2026.
What is the market cap of National Research Corporation (Delaware) (NRC)?
National Research Corporation (Delaware) (NRC) has a market capitalisation of $ 468 Mln as on 11-Sep-2026. As per SEBI classification, it is a Small Cap company.
Should I invest in National Research Corporation (Delaware) (NRC)?
Before investing in National Research Corporation (Delaware) (NRC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.